ILUMYA ® (tildrakizumab-asmn) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy …

Dec 12, 2024 · Ilumya injection is used for moderate-to-severe plaque psoriasis to help reduce plaques, scales, and redness, making the skin clearer and less itchy. Ilumya works to balance the overactive …

May 13, 2022 · Ilumya (tildrakizumab-asmn) is a prescription injection that treats plaque psoriasis in adults. Learn about Ilumya's dosage, side effects, and more.

Learn about ILUMYA® (tildrakizumab-asmn), an IL-23 inhibitor injection indicated for adult patients with moderate-to-severe plaque psoriasis (PsO).

Nov 28, 2024 · Ilumya is administered by subcutaneous injection every 12 weeks (after an initial loading dose) and may be used to reduce inflammation associated with psoriasis but it needs to be …

Jul 22, 2025 · Ilumya injection is FDA-approved to treat adults with moderate-to-severe plaque psoriasis. If you or anyone you love is living with plaque psoriasis, this article will cover everything you need to …

Apr 23, 2024 · Ilumya (tildrakizumab-asmn) is commonly used to treat people with moderate to severe plaque psoriasis who may benefit from an injection, pill, or ultraviolet (UV) light therapy.

Learn how the biologic injection, ILUMYA® works for moderate-to-severe plaque psoriasis. See the full Prescribing Info and Medication Guide.

May 1, 2025 · Learn about Ilumya (tildrakizumab) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.

ILUMYA® is a prescription medication that treats moderate-to-severe plaque psoriasis in adults. It belongs to a group of medications called IL-23 inhibitors Ilumyapro, which work by targeting a …